Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs911541 | chr10:101433392 | A/G | 1.97E-5 | 178 | 24.17 | 28.3 | 6.1 | KM Plot |
PCPG | rs912467 | chr10:50594368 | T/G | 4.44E-6 | 174 | 24.53 | 34.93 | 25.17 | KM Plot |
PCPG | rs913859 | chr1:153620086 | A/G | 0.000353 | 178 | 5.68 | 27.27 | 25.17 | KM Plot |
PCPG | rs920556 | chr2:176189259 | A/G | 0.000121 | 177 | 25.4 | 28.95 | 6.62 | KM Plot |
PCPG | rs921153 | chr2:61563408 | G/A | 0.000474 | 177 | 24.1 | 30.18 | 17.85 | KM Plot |
PCPG | rs925725 | chr3:80567282 | C/A | 6.03E-5 | 178 | 19.53 | 24.03 | 27.23 | KM Plot |
PCPG | rs925728 | chr3:80570649 | C/T | 4.16E-5 | 178 | 19.87 | 23.53 | 27.23 | KM Plot |
PCPG | rs925729 | chr3:80570653 | T/A | 4.16E-5 | 178 | 19.87 | 23.53 | 27.23 | KM Plot |
PCPG | rs9282681 | chr16:89805914 | T/C | 0.000188 | 175 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs9289198 | chr3:122277160 | G/T | 9.09E-5 | 175 | 25 | 25.97 | 10.3 | KM Plot |
PCPG | rs9289199 | chr3:122277172 | G/A | 9.09E-5 | 175 | 25 | 25.97 | 10.3 | KM Plot |
PCPG | rs9291739 | chr5:50608685 | G/A | 7.07E-5 | 176 | 25.28 | 24.62 | 31.35 | KM Plot |
PCPG | rs9295697 | chr6:26558531 | T/C | 7.27E-7 | 176 | 10.68 | 32.6 | 24.53 | KM Plot |
PCPG | rs930177 | chr2:236194008 | A/G | 2.27E-7 | 175 | 25.97 | 25.05 | 3.07 | KM Plot |
PCPG | rs9315458 | chr13:37544226 | C/T | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |